Tirzepatide online access for Tuscaloosa, Alabama
Company statements checked September 10, 2026: 1 covered company — Gentle Health — advertises online access to Tirzepatide for patients in Alabama, including Tuscaloosa. Confirm eligibility and total charges with the provider.
Browse online Tirzepatide programs advertised for patients in Tuscaloosa, Alabama, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded injectable tirzepatide | $169/mo advertised monthly bundle, Compounded injectable tirzepatide | Official site ↗ |
Health context in Tuscaloosa
Tirzepatide programs are marketed for weight management and, for some products, type 2 diabetes. These Tuscaloosa figures give local context only. Among the 5 Alabama cities in this research set, Tuscaloosa has the highest estimate for routine checkup in the past year among adults (82%).
| Measure | Tuscaloosa | 95% range | Among the 5 Alabama cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 46.6% | 40.7–52.3% | second-highest | 2023 |
| Diagnosed diabetes among adults | 15% | 13.2–16.8% | fourth-highest | 2023 |
| High blood pressure among adults | 44.5% | 40.7–48.2% | second-highest | 2023 |
| Lack of health insurance among adults aged 18–64 | 11.2% | 9.7–12.8% | third-highest | 2023 |
| Routine checkup in the past year among adults | 82% | 79–84.8% | highest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 99,600); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
Gentle Health’s compounded injectable tirzepatide is the named offer in this Alabama statewide online listing for Tuscaloosa. That product identity matters when reading the quote: the entry does not establish access to branded Zepbound or Mounjaro.
The Alabama guide explains the selected program’s cash-pay tiers and ordering terms. Keep the compounded preparation attached to price and fulfillment questions.
These are online services advertised for patients in Alabama, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Tuscaloosa, and a listing is not a prescription, appointment or coverage guarantee. Read the Alabama Tirzepatide guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's compounded injectable tirzepatide program, if prescribed, billed through its medication-order subscription.
Compounded injectable tirzepatide (injection): 2.5–5 mg/week — $169/mo · >5–10 mg/week — $219/mo · >10–15 mg/week — $269/mo
- Compounded injectable tirzepatide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
Health center sites with Tuscaloosa addresses
If you want an in-person visit, HRSA-listed health center sites with Tuscaloosa postal addresses include:
- Maude L. Whatley Health Center (Whatley Health Services Inc) — 2731 Ml King Jr Blvd, Tuscaloosa, AL 35401 · 205-758-6647
From the HRSA health center directory (data retrieved ), listed alphabetically by organization and matched by postal address, not city boundaries; the list includes health center look-alikes, which do not receive Health Center Program funding. Not a ranking or recommendation. Call to confirm services, costs and whether a site can help with the programs on this page.
More listings
Other medications for Tuscaloosa: GLP-1 medication access · Semaglutide
Tirzepatide in other Alabama cities: Birmingham · Huntsville · Mobile · Montgomery
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.